MedTrace Logo

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

NCT00575302 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2010-04-13

No results posted yet for this study

Summary

In In vitro fertilization (IVF) treatment, poor responder patients of more than 38 years old are randomized prospectively into two dosages of gonadotrophins. The outcome of treatment will be analyzed.

Conditions

Interventions

DRUG

Gonal-f®: follitropin alpha

Gonal-f®: follitropin alpha, administration of 300 U

DRUG

Gonal-f®: follitropin alpha

Gonal-f®: follitropin alpha, administration of 450 U

Sponsors & Collaborators

  • EMD Serono

    collaborator INDUSTRY

  • Centre Hospitalier Chretien

    lead OTHER

Principal Investigators

  • Annick Delvigne, PhD · CHC Saint-Vincent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
38 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575302 on ClinicalTrials.gov